Timothy Hoey
Chief Tech/Sci/R&D Officer at TENAYA THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Dr. Timothy Hoey is a Chief Scientific Officer at Tenaya Therapeutics, Inc. Dr. Hoey was previously employed as a Co-Chief Scientific Officer & SVP-Cancer Biology by OncoMed Pharmaceuticals, Inc., a Director-Biology Department by Amgen, Inc., and a Director-Biology Department by Tularik, Inc. He received his undergraduate degree from the University of Michigan and a doctorate degree from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-04 | 245,346 ( 0.31% ) | 1 M $ | 2024-03-30 |
Timothy Hoey active positions
| Companies | Position | Start |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2017-07-31 |
Former positions of Timothy Hoey
| Companies | Position | End |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 2016-12-31 |
| AMGEN INC. | Corporate Officer/Principal | 2004-12-31 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director/Board Member | 2011-12-13 |
Training of Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy Hoey
